Earnings History Data for Heron Therapeutics, Inc. (HRTX) - NYSE NASDAQ

To lookup another company type a stock symbol and press 'Go'. The overview will show the earnings release info that is available in TheStockCatalyst database for the company.

For historic stock the Extended Hours price data shown are from just before market open on the day of release for premarket earnings releases and of the day after release for afterhours earnings releases. The normal price data is from just before market close on the days of release for premarket releases and the day after release for afterhours releases.

See the full list of available companies here.

Heron Therapeutics, Inc.

Heron Therapeutics Inc. is a specialty pharmaceutical company. The company is developing products using its proprietary Biochronomer (TM) polymer-based drug delivery platform. Its product portfolio includes APF530, is being developed for the prevention of acute chemotherapy-induced nausea and vomiting. Heron Therapeutics Inc., formerly known as A.P. Pharma, Inc., is based in REDWOOD CITY CA.

Release Date	Time	Est. Time	Symbol	Name	Market Cap (M)	Rep. EPS	Est. EPS	Last years EPS	SeekingAlpha Headline	Price	Change	Ext. Hours Price	Ext. Hours Change	52 Week Range	Volume	Avg. Volume	Ext. Hours Volume
12-11-2024	PM		HRTX	Heron Therapeutics, Inc.	265.42	-0.03	-0.03	-0.17	Heron Therapeutics GAAP EPS of -$0.03 in-line, revenue of $32.81M misses by $4.12M [11/12/2024 8:00 AM]	1.27	-0.57 (-30.71%)	1.15	-0.69 (-37.36%)	0.53 - 3.93	9,898,646	1,390,000	471,281
Heron Therapeutics GAAP EPS of -$0.03 in-line, revenue of $32.81M misses by $4.12M [11/12/2024 8:00 AM] Heron Therapeutics Announces Third Quarter 2024 Financial Results and Narrows Financial Guidance [2024-11-12 07:55AM]
06-08-2024	AH		HRTX	Heron Therapeutics, Inc.	423.34	-0.06	-0.04	-0.35	Heron Therapeutics GAAP EPS of -$0.06 misses by $0.02, revenue of $36.02M beats by $0.13M [8/6/2024 4:45 PM]	1.99	-0.68 (-25.66%)	2.52	-0.15 (-5.62%)	0.50 - 3.93	8,684,137	2,040,000	45,606
Heron Therapeutics GAAP EPS of -$0.06 misses by $0.02, revenue of $36.02M beats by $0.13M [8/6/2024 4:45 PM]
07-05-2024	PM		HRTX	Heron Therapeutics	384.00	-0.02	-0.08	0.00	Heron Therapeutics GAAP EPS of -$0.02, revenue of $34.67M [5/7/2024 8:02 AM]	2.87	0.03 (0.88%)	3.03	0.19 (6.69%)	0.50 - 3.22	6,604,908	2,560,000	297,860
Heron Therapeutics Q1 2024 Earnings Preview [5/6/2024 10:57 AM] Heron Therapeutics GAAP EPS of -$0.02, revenue of $34.67M [5/7/2024 8:02 AM]
12-03-2024	AH		HRTX	Heron Therapeutics, Inc.	390.19	-0.07	-0.15	-0.17	Heron Therapeutics GAAP EPS of -$0.07 beats by $0.09, revenue of $34.22M beats by $3M [3/12/2024 4:05 PM]	3.00	0.64 (27.12%)	2.78	0.42 (17.80%)	0.50 - 3.22	17,331,413	2,010,000	118,946
Heron Therapeutics GAAP EPS of -$0.07 beats by $0.09, revenue of $34.22M beats by $3M [3/12/2024 4:05 PM]
14-11-2023	AH		HRTX	Heron Therapeutics, Inc.	82.40	-0.17	-0.31	-0.38	Heron Therapeutics GAAP EPS of -$0.17 beats by $0.14, revenue of $31.43M misses by $0.4M [11/14/2023 4:08 PM]	0.8516	0.31 (57.70%)	0.73	0.19 (35.17%)	0.50 - 3.49	20,452,746	2,420,000	1,015,804
Heron Therapeutics GAAP EPS of -$0.17 beats by $0.14, revenue of $31.43M misses by $0.4M [11/14/2023 4:08 PM]
14-08-2023	AH		HRTX	Heron Therapeutics, Inc.	207.11	-0.35	-0.23	-0.55	Heron Therapeutics GAAP EPS of -$0.35 misses by $0.12, revenue of $31.76M beats by $0.06M [8/14/2023 4:07 PM]	1.68	0.17 (10.93%)	1.42	-0.09 (-5.96%)	1.07 - 5.62	4,171,894	2,430,000	18,149
Heron Therapeutics GAAP EPS of -$0.35 misses by $0.12, revenue of $31.76M beats by $0.06M [8/14/2023 4:07 PM]
11-05-2023	AH	4:05 PM ET (May 11)	HRTX	Heron Therapeutics, Inc.	291.04	-0.27	-0.17	-0.63	Heron Therapeutics GAAP EPS of -$0.27 misses by $0.07, revenue of $29.62M misses by $0.07M [5/11/2023 4:03 PM]	1.41	-0.82 (-37.00%)	2.21	-0.02 (-0.90%)	1.28 - 5.62	14,073,938	1,410,000	51,186
Heron Therapeutics GAAP EPS of -$0.27 misses by $0.07, revenue of $29.62M misses by $0.07M [5/11/2023 4:03 PM] Heron stock slumps ~35% amid quarterly misses on both lines [5/12/2023 11:50 AM]
23-03-2023	AH	4:05 PM ET (Mar 23)	HRTX	Heron Therapeutics, Inc.	321.00	-0.17	-0.25	-0.54	Heron Therapeutics GAAP EPS of -$0.17 beats by $0.15, revenue of $30.03M beats by $2.79M [3/23/2023 4:06 PM]	1.91	-0.16 (-7.75%)	2.20	0.14 (6.54%)	1.80 - 6.38	3,808,747	1,640,000	130,839
Heron Therapeutics GAAP EPS of -$0.17 beats by $0.15, revenue of $30.03M beats by $2.79M [3/23/2023 4:06 PM] Heron stock falls ~10% as headwinds for Zynrelef label, device delivery linger [3/24/2023 11:31 AM]
08-11-2022	AH	4:05 PM ET (Nov 8)	HRTX	Heron Therapeutics, Inc.	400.27	-0.38	-0.39	-0.51	Heron Therapeutics reports Q3 results, affirms FY oncology care franchise revenue guidance [11/8/2022 4:47 PM]	3.00	-0.46 (-13.19%)	3.40	-0.05 (-1.45%)	2.19 - 12.71	3,631,022	1,820,000	1,072
Heron Therapeutics reports Q3 results, affirms FY oncology care franchise revenue guidance [11/8/2022 4:47 PM] Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2022 and Highlights Recent Corporate Updates [Nov-08-22 04:05PM]
09-08-2022	PM	8:00 AM ET (Aug 9)	HRTX	Heron Therapeutics, Inc.	279.77	-0.55	-0.50	-0.62	Heron Therapeutics GAAP EPS of -$0.55 misses by $0.05, revenue of $27.63M beats by $2.98M [8/9/2022 8:02 AM]	4.15	0.58 (16.25%)	3.38	-0.19 (-5.32%)	2.19 - 12.89	6,773,489	2,720,000	50,207
Heron Therapeutics Q2 2022 Earnings Preview [8/8/2022 1:59 PM] Heron Therapeutics GAAP EPS of -$0.55 misses by $0.05, revenue of $27.63M beats by $2.98M [8/9/2022 8:02 AM] Heron Therapeutics to raise $76.5M in stock and warrants offering [8/9/2022 8:36 AM] Heron Therapeutics rises 16% on Q2 revenue beat, raises 2022 sales forecast [8/9/2022 11:18 AM] Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2022 and Highlights Recent Corporate Updates [Aug-09-22 08:00AM] Heron Therapeutics (HRTX) Reports Q2 Loss, Tops Revenue Estimates [Aug-09-22 09:15AM] Heron Therapeutics Announces $76.5 Million Private Placement Financing [Aug-09-22 08:01AM]
09-05-2022	AH	4:05 PM ET (May 9)	HRTX	Heron Therapeutics, Inc.	453.09	-0.63	-0.45	-0.58	Heron Therapeutics GAAP EPS of -$0.63 misses by $0.15, revenue of $23.46M beats by $0.85M [5/9/2022 4:43 PM]	3.56	-0.04 (-1.25%)	3.88	0.27 (7.48%)	3.60 - 18.53	3,952,071	2,396,836	4,673
Heron Therapeutics GAAP EPS of -$0.63 misses by $0.15, revenue of $23.46M beats by $0.85M [5/9/2022 4:43 PM] Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2022 and Highlights Recent Corporate Updates [May-09-22 04:05PM] Heron Therapeutics (HRTX) Reports Q1 Loss, Tops Revenue Estimates [May-09-22 06:45PM]
28-02-2022	AH	4:00 PM ET (Feb 28)	HRTX	Heron Therapeutics, Inc.	770.63	-0.54	-0.59	-0.68	Heron Therapeutics GAAP EPS of -$0.54 beats by $0.04, revenue of $20.66M misses by $5.11M [2/28/2022 4:20 PM]	5.75	-1.34 (-18.94%)	5.48	-1.62 (-22.82%)	5.34 - 18.99	5,728,022	1,900,000	121,343
Heron Therapeutics GAAP EPS of -$0.54 beats by $0.04, revenue of $20.66M misses by $5.11M [2/28/2022 4:20 PM] Heron stock falls 21% as Q4 sales remain largely flat Y/Y [3/1/2022 10:38 AM] Heron Therapeutics Announces Financial Results for the Three and Twelve Months Ended December 31, 2021 and Highlights Recent Corporate Updates [Feb-28-22 04:05PM] Heron Therapeutics (HRTX) Reports Q4 Loss, Lags Revenue Estimates [Feb-28-22 05:45PM] Why Heron Therapeutics Stock Is Getting Hammered Today [Mar-01-22 03:38PM]
03-11-2021	AH	4:05 PM ET (Nov 3)	HRTX	Heron Therapeutics, Inc.	1,160	-0.51	-0.60	-0.64	Heron Therapeutics EPS beats by $0.10, misses on revenue [11/3/2021 4:10 PM]	11.53	0.24 (2.13%)	11.20	-0.09 (-0.80%)	9.87 - 22.40	1,242,377	1,910,000	58,771
Heron Therapeutics EPS beats by $0.10, misses on revenue [11/3/2021 4:10 PM] Heron Therapeutics Announces Financial Results for the Three and Nine Months Ended September 30, 2021 and Highlights Recent Corporate Updates [Nov-03-21 04:01PM] Heron Therapeutics (HRTX) Reports Q3 Loss, Misses Revenue Estimates [Nov-03-21 06:05PM]
09-08-2021	PM	8:30 AM ET (Aug 9)	HRTX	Heron Therapeutics, Inc.	1,215	-0.62	-0.59	0.00	Heron Therapeutics EPS misses by $0.06, misses on revenue [8/9/2021 8:39 AM]	11.91	0.11 (0.93%)	11.35	-0.45 (-3.81%)	11.36 - 22.40	1,942,066	1,290,000	235,752
Heron Therapeutics EPS misses by $0.06, misses on revenue [8/9/2021 8:39 AM] Heron Therapeutics Announces Financial Results for the Three and Six Months Ended June 30, 2021 and Highlights Recent Corporate Updates [Aug-09-21 08:00AM] Heron Therapeutics (HRTX) Reports Q2 Loss, Misses Revenue Estimates [Aug-09-21 09:15AM]
10-05-2021	PM	8:30 AM ET (May 10)	HRTX	Heron Therapeutics, Inc.	1,533	-0.58	-0.57	0.00	Heron Therapeutics EPS misses by $0.03, misses on revenue [5/10/2021 8:44 AM]	17.60	0.97 (5.83%)	16.79	0.16 (0.96%)	12.52 - 22.40	2,319,753	1,050,000	27,266
Heron Therapeutics EPS misses by $0.03, misses on revenue [5/10/2021 8:44 AM] Heron Therapeutics climbs on management comments on upcoming milestone [5/10/2021 10:51 AM] Heron Therapeutics Announces Financial Results for the Three Months Ended March 31, 2021 and Highlights Recent Corporate Updates [May-10-21 08:30AM] Heron Therapeutics (HRTX) Reports Q1 Loss, Misses Revenue Estimates [May-10-21 09:45AM] Why Heron Therapeutics Stock Jumped Today [May-10-21 03:33PM]
24-02-2021	PM	8:30 AM ET (Feb 24)	HRTX	Heron Therapeutics, Inc.	1,672	-0.68	-0.68	0.00	Heron Therapeutics EPS misses by $0.03, beats on revenue [2/24/2021 8:57 AM]	19.30	1.44 (8.06%)	18.01	0.15 (0.84%)	9.60 - 22.40	759,592	627,655	490
Heron Therapeutics EPS misses by $0.03, beats on revenue [2/24/2021 8:57 AM]